Thomas Cerny
Patient and General Population Preferences Regarding the Benefits and Harms of Treatment for Metastatic Prostate Cancer: A Discrete Choice Experiment.
Menges D, Piatti M, Omlin A, Cathomas R, Benamran D, Fischer S, Iselin C, Kueng M, Lorch A, Prause L, Rothermundt C, O'Meara Stern A, Zihler D, Lippuner M, Braun J, Cerny T, Puhan M. Patient and General Population Preferences Regarding the Benefits and Harms of Treatment for Metastatic Prostate Cancer: A Discrete Choice Experiment. Eur Urol Open Sci 2023; 51:26-38.
22.03.2023Patient and General Population Preferences Regarding the Benefits and Harms of Treatment for Metastatic Prostate Cancer: A Discrete Choice Experiment.
22.03.2023Eur Urol Open Sci 2023; 51:26-38
Menges Dominik, Piatti Michela C, Omlin Aurelius, Cathomas Richard, Benamran Daniel, Fischer Stefanie, Iselin Christophe E, Kueng Marc, Lorch Anja, Prause Lukas, Rothermundt Christian, O'Meara Stern Alix, Zihler Deborah, Lippuner Max, Braun Julia, Cerny Thomas, Puhan Milo Alan
All Men Are Created Equal: Addressing Disparities in Prostate Cancer Care
Borno H, George D, Schnipper L, Cavalli F, Cerny T, Gillessen Sommer S. All Men Are Created Equal: Addressing Disparities in Prostate Cancer Care. Am Soc Clin Oncol Educ Book 2019; 39:302-308.
17.05.2019All Men Are Created Equal: Addressing Disparities in Prostate Cancer Care
17.05.2019Am Soc Clin Oncol Educ Book 2019; 39:302-308
Borno Hala, George Daniel J, Schnipper Lowell E, Cavalli Franco, Cerny Thomas, Gillessen Sommer Silke
Lung cancer and smoking trends in the young in Switzerland: a study based on data of the National Institute for Cancer Epidemiology and Registration and of the Swiss Health Surveys
Mousavi S, Schmid S, Cerny T, Früh M. Lung cancer and smoking trends in the young in Switzerland: a study based on data of the National Institute for Cancer Epidemiology and Registration and of the Swiss Health Surveys. Swiss Med Wkly 2018; 148:w14708.
30.12.2018Lung cancer and smoking trends in the young in Switzerland: a study based on data of the National Institute for Cancer Epidemiology and Registration and of the Swiss Health Surveys
30.12.2018Swiss Med Wkly 2018; 148:w14708
Mousavi Seyed Mohsen, Schmid Sabine, Cerny Thomas, Früh Martin
Reply to technical comment on: Güller et al. Lower hospital volume is associated with higher mortality after oesophageal, gastric, pancreatic and rectal cancer resection
Guebeli N, Warschkow R, Ackermann C, Schmied B, Cerny T, ess s. Reply to technical comment on: Güller et al. Lower hospital volume is associated with higher mortality after oesophageal, gastric, pancreatic and rectal cancer resection. Swiss Med Wkly 2018; 148:w14583.
29.01.2018Reply to technical comment on: Güller et al. Lower hospital volume is associated with higher mortality after oesophageal, gastric, pancreatic and rectal cancer resection
29.01.2018Swiss Med Wkly 2018; 148:w14583
Guebeli Nadia, Warschkow Rene, Ackermann Christoph Jakob, Schmied Bruno, Cerny Thomas, ess silvia
Lower hospital volume is associated with higher mortality after oesophageal, gastric, pancreatic and rectal cancer resection
Gueller U, Warschkow R, Ackermann C, Schmied B, Cerny T, ess s. Lower hospital volume is associated with higher mortality after oesophageal, gastric, pancreatic and rectal cancer resection. Swiss Med Wkly 2017; 147:w14473.
27.07.2017Lower hospital volume is associated with higher mortality after oesophageal, gastric, pancreatic and rectal cancer resection
27.07.2017Swiss Med Wkly 2017; 147:w14473
Gueller Ulrich, Warschkow Rene, Ackermann Christoph Jakob, Schmied Bruno, Cerny Thomas, ess silvia
Multiple primary tumours: challenges and approaches, a review
Vogt A, Schmid S, Heinimann K, Frick H, Herrmann C, Cerny T, Omlin A. Multiple primary tumours: challenges and approaches, a review. ESMO Open 2017; 2:e000172.
02.05.2017Multiple primary tumours: challenges and approaches, a review
02.05.2017ESMO Open 2017; 2:e000172
Vogt Alexia, Schmid Sabine, Heinimann Karl, Frick Harald, Herrmann Christian, Cerny Thomas, Omlin Aurelius
Early Postoperative FDG-PET-CT Imaging Results in a Relevant Upstaging in the pN2 Subgroup of Stage III Colorectal Cancer Patients
Fehr M, Müller J, Knitel M, Fornaro J, Horber D, Koeberle D, Cerny T, Gueller U. Early Postoperative FDG-PET-CT Imaging Results in a Relevant Upstaging in the pN2 Subgroup of Stage III Colorectal Cancer Patients. Clin Colorectal Cancer 2017
21.03.2017Early Postoperative FDG-PET-CT Imaging Results in a Relevant Upstaging in the pN2 Subgroup of Stage III Colorectal Cancer Patients
21.03.2017Clin Colorectal Cancer 2017
Fehr Martin, Müller Joachim, Knitel Meinhard, Fornaro Jürgen, Horber Daniel, Koeberle Dieter, Cerny Thomas, Gueller Ulrich
Secondary malignancies after rectal cancer resection with and without radiation therapy: A propensity-adjusted, population-based SEER analysis
Warschkow R, Gueller U, Cerny T, Schmied B, Plasswilm L, Putora P. Secondary malignancies after rectal cancer resection with and without radiation therapy: A propensity-adjusted, population-based SEER analysis. Radiother Oncol 2017; 123:139-146.
09.03.2017Secondary malignancies after rectal cancer resection with and without radiation therapy: A propensity-adjusted, population-based SEER analysis
09.03.2017Radiother Oncol 2017; 123:139-146
Warschkow Rene, Gueller Ulrich, Cerny Thomas, Schmied Bruno, Plasswilm Ludwig, Putora Paul Martin
Better survival in right-sided versus left-sided stage I - III colon cancer patients
Warschkow R, Sulz M, Marti L, Tarantino I, Schmied B, Cerny T, Gueller U. Better survival in right-sided versus left-sided stage I - III colon cancer patients. BMC cancer 2016; 16:554.
28.07.2016Better survival in right-sided versus left-sided stage I - III colon cancer patients
28.07.2016BMC cancer 2016; 16:554
Warschkow Rene, Sulz Michael, Marti Lukas, Tarantino Ignazio, Schmied Bruno, Cerny Thomas, Gueller Ulrich
Erlotinib has comparable clinical efficacy to chemotherapy in pretreated patients with advanced non-small cell lung cancer (NSCLC): A propensity-adjusted, outcomes research-based study
Neumair P, Cerny T, Krähenbühl S, Baty F, Brutsche M, Früh M, Hitz F, Ess S, Dutly A, Warschkow R, Joos L, Jörger M. Erlotinib has comparable clinical efficacy to chemotherapy in pretreated patients with advanced non-small cell lung cancer (NSCLC): A propensity-adjusted, outcomes research-based study. Lung Cancer 2016; 100:38-44.
28.07.2016Erlotinib has comparable clinical efficacy to chemotherapy in pretreated patients with advanced non-small cell lung cancer (NSCLC): A propensity-adjusted, outcomes research-based study
28.07.2016Lung Cancer 2016; 100:38-44
Neumair P, Cerny Thomas, Krähenbühl S, Baty Florent, Brutsche Martin, Früh Martin, Hitz Felicitas, Ess S, Dutly A, Warschkow Rene, Joos L, Jörger Markus
Improved Survival After Primary Tumor Surgery in Metastatic Breast Cancer: A Propensity-adjusted, Population-based SEER Trend Analysis
Warschkow R, Gueller U, Tarantino I, Cerny T, Schmied B, Thürlimann B, Jörger M. Improved Survival After Primary Tumor Surgery in Metastatic Breast Cancer: A Propensity-adjusted, Population-based SEER Trend Analysis. Ann Surg 2016; 263:1188-98.
01.06.2016Improved Survival After Primary Tumor Surgery in Metastatic Breast Cancer: A Propensity-adjusted, Population-based SEER Trend Analysis
01.06.2016Ann Surg 2016; 263:1188-98
Warschkow Rene, Gueller Ulrich, Tarantino Ignazio, Cerny Thomas, Schmied Bruno, Thürlimann Beat, Jörger Markus
[Reasons for General Practitioner Shortage – a Comparison Between France and Switzerland]
Cerny T, Rosemann T, Tandjung R, Corinne C. [Reasons for General Practitioner Shortage – a Comparison Between France and Switzerland]. Praxis (Bern 1994) 2016; 105:619-36.
25.05.2016[Reasons for General Practitioner Shortage – a Comparison Between France and Switzerland]
25.05.2016Praxis (Bern 1994) 2016; 105:619-36
Cerny Thomas, Rosemann Thomas, Tandjung Ryan, Corinne Chmiel
A population-based analysis of secondary malignancies in breast cancer patients receiving breast reconstruction
Warschkow R, Cerny T, Schmied B, Gueller U, Thürlimann B, Jörger M. A population-based analysis of secondary malignancies in breast cancer patients receiving breast reconstruction. Br J Cancer 2016; 115:80-4.
17.05.2016A population-based analysis of secondary malignancies in breast cancer patients receiving breast reconstruction
17.05.2016Br J Cancer 2016; 115:80-4
Warschkow Rene, Cerny Thomas, Schmied Bruno, Gueller Ulrich, Thürlimann Beat, Jörger Markus
Predictive Value of CEA for Survival in Stage I Rectal Cancer: a Population-Based Propensity Score-Matched Analysis
Tarantino I, Warschkow R, Schmied B, Gueller U, Mieth M, Cerny T, Büchler M, Ulrich A. Predictive Value of CEA for Survival in Stage I Rectal Cancer: a Population-Based Propensity Score-Matched Analysis. J Gastrointest Surg 2016; 20:1213-22.
11.04.2016Predictive Value of CEA for Survival in Stage I Rectal Cancer: a Population-Based Propensity Score-Matched Analysis
11.04.2016J Gastrointest Surg 2016; 20:1213-22
Tarantino Ignazio, Warschkow Rene, Schmied Bruno, Gueller Ulrich, Mieth Markus, Cerny Thomas, Büchler Markus W, Ulrich Alexis
Revisiting a dogma: similar survival of patients with small bowel and gastric GIST. A population-based propensity score SEER analysis
Gueller U, Tarantino I, Cerny T, Ulrich A, Schmied B, Warschkow R. Revisiting a dogma: similar survival of patients with small bowel and gastric GIST. A population-based propensity score SEER analysis. Gastric Cancer 2015
09.12.2015Revisiting a dogma: similar survival of patients with small bowel and gastric GIST. A population-based propensity score SEER analysis
09.12.2015Gastric Cancer 2015
Gueller Ulrich, Tarantino Ignazio, Cerny Thomas, Ulrich Alexis, Schmied Bruno, Warschkow Rene
Population-based SEER trend analysis of overall and cancer-specific survival in 5138 patients with gastrointestinal stromal tumor
Gueller U, Tarantino I, Cerny T, Schmied B, Warschkow R. Population-based SEER trend analysis of overall and cancer-specific survival in 5138 patients with gastrointestinal stromal tumor. BMC cancer 2015; 15:557.
30.07.2015Population-based SEER trend analysis of overall and cancer-specific survival in 5138 patients with gastrointestinal stromal tumor
30.07.2015BMC cancer 2015; 15:557
Gueller Ulrich, Tarantino Ignazio, Cerny Thomas, Schmied Bruno, Warschkow Rene
Using lung cancer mortality to indirectly approximate smoking patterns in space
Jürgens V, ess s, Schwenkglenks M, Cerny T, Vounatsou P. Using lung cancer mortality to indirectly approximate smoking patterns in space. Spat Spatiotemporal Epidemiol 2015; 14-15:23-31.
13.07.2015Using lung cancer mortality to indirectly approximate smoking patterns in space
13.07.2015Spat Spatiotemporal Epidemiol 2015; 14-15:23-31
Jürgens Verena, ess silvia, Schwenkglenks Matthias, Cerny Thomas, Vounatsou Penelope
[Osteosarcomas: very rare but curable with your help]
Cerny T. [Osteosarcomas: very rare but curable with your help]. Praxis (Bern 1994) 2015; 104:657.
17.06.2015[Osteosarcomas: very rare but curable with your help]
17.06.2015Praxis (Bern 1994) 2015; 104:657
Cerny Thomas
Germline TYMS genotype is highly predictive in patients with metastatic gastrointestinal malignancies receiving capecitabine-based chemotherapy
Jörger M, Beijnen J, Cerny T, Meulendijks D, Zueger M, Meijerman I, Rosing H, Vainchtein L, Smits P, Doodeman V, Cats A, Boot H, Huitema A, Schellens J. Germline TYMS genotype is highly predictive in patients with metastatic gastrointestinal malignancies receiving capecitabine-based chemotherapy. Cancer Chemother Pharmacol 2015; 75:763-72.
13.02.2015Germline TYMS genotype is highly predictive in patients with metastatic gastrointestinal malignancies receiving capecitabine-based chemotherapy
13.02.2015Cancer Chemother Pharmacol 2015; 75:763-72
Jörger Markus, Beijnen J H, Cerny Thomas, Meulendijks D, Zueger M, Meijerman I, Rosing H, Vainchtein L, Smits P H M, Doodeman V D, Cats A, Boot H, Huitema A D R, Schellens J H M
Prognostic Relevance of Palliative Primary Tumor Removal in 37,793 Metastatic Colorectal Cancer Patients: A Population-Based, Propensity Score-Adjusted Trend Analysis
Tarantino I, Warschkow R, Worni M, Cerny T, Ulrich A, Schmied B, Gueller U. Prognostic Relevance of Palliative Primary Tumor Removal in 37,793 Metastatic Colorectal Cancer Patients: A Population-Based, Propensity Score-Adjusted Trend Analysis. Ann Surg 2014; 262:112-120.
04.11.2014Prognostic Relevance of Palliative Primary Tumor Removal in 37,793 Metastatic Colorectal Cancer Patients: A Population-Based, Propensity Score-Adjusted Trend Analysis
04.11.2014Ann Surg 2014; 262:112-120
Tarantino Ignazio, Warschkow Rene, Worni Mathias, Cerny Thomas, Ulrich Alexis, Schmied Bruno, Gueller Ulrich